vaccine

Until two years ago, mRNA vaccines had never been approved. Now, vast research offers hope in treating more than COVID-19

Until two years ago, mRNA vaccines had never been approved. Now, vast research offers hope in treating more than COVID-19

Illustration by Romain Lasser When Momar Ndao looks at the ingeniousness of the mRNA technology behind the COVID-19 vaccines, he sees hope in the fight against a category of diseases that blinded his mother and killed his uncle. As a parasitologist and professor in the division of Experimental Medicine at McGill University, Dr. Ndao studies …

Until two years ago, mRNA vaccines had never been approved. Now, vast research offers hope in treating more than COVID-19 Read More »

Novavax confident Covid vaccine will receive FDA authorization in June after delays

Novavax confident Covid vaccine will receive FDA authorization in June after delays

Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is scheduled to meet on June 7 to review Novavax’s submission. An endorsement from the committee, which is made up of independent experts, would mean the drug …

Novavax confident Covid vaccine will receive FDA authorization in June after delays Read More »

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age | NEJM

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age | NEJM

Trial Population Between March and August 2021, a total of 751 participants who were 6 to 11 years of age were enrolled in part 1 of the trial and 4016 participants were enrolled in part 2. In part 1, all 380 participants who were enrolled in the 50-μg dose-level mRNA-1273 group and 371 participants who …

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age | NEJM Read More »

Emergent's Covid vaccine problems more extensive than previously known

Emergent’s Covid vaccine problems more extensive than previously known

The details of the investigation by the House Select Subcommittee on the Coronavirus Crisis and the Committee on Oversight and Reform, released Tuesday, which include troves of internal emails, underscore the degree to which Emergent staff and consultants working with the company knew of the extensive issues at Bayview before moving forward with U.S. government …

Emergent’s Covid vaccine problems more extensive than previously known Read More »